US private equity PE firm Platinum Equity has acquired a controlling stake in Inventia Healthcare’s core Oral Solid Dosage OSD business from PE firm Invascent’s India Life Sciences Fund III, New York Life Investment Management's Jacob Ballas India Fund III and affiliates of the company's founding Shah family.
The Shah family is retaining a minority stake in Inventia. Invengene and Nutriventia, the injectables and nutraceuticals businesses, respectively, are not part of the transaction and are being retained separately by the Shah family, according to an August 30 media release.
Financial terms of the acquisition or the size of the stake were not disclosed.
...
¬ Haymarket Media Limited. All rights reserved.
